Brittany Greenbaum, DO
Otolaryngology · Casper, WYNPI 1952793416
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $786 of the $1,094 with a category attached, or 71.9%. Inspire Medical Systems, Inc. accounts for 62.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2022 at $522 and has fallen 80.1% since, to $104 in 2025.
Across 21 payments — averaging $52.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$684
- Cochlear Americas$157
- Regeneron Healthcare Solutions, Inc.$69
- Aerin Medical Inc.$62
- Optinose US, Inc.$49
- Sanofi$16
- plus $57 from 4 others
What the payments were for
- Travel & lodging$30828%
- Food & beverage$78672%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 5 | $684 |
| Cochlear Americas | 2 | $157 |
| Regeneron Healthcare Solutions, Inc. | 4 | $69 |
| Aerin Medical Inc. | 2 | $62 |
| Optinose US, Inc. | 3 | $49 |
| Sanofi | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| KCI USA, Inc. | 1 | $15 |
| Integra Lifesciences Corporation | 1 | $15 |
| Medtronic | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire Upper Airway Stimulation System$479
- Nucleus$135
- Baha$135
- Inspire$107
How this compares
Too few otolaryngology providers in Wyomingto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 26 | $543 |
| Ofloxacin | 13 | $513 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $474 |
| Azelastine Hcl | 13 | $383 |
| Fluticasone Propionate | 14 | $265 |
| Pantoprazole Sodium | 24 | $186 |
| Mupirocin | 20 | $141 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $97 |
| Famotidine | 26 | $77 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Casper
- David NorcrossCasper$2K
- Caleb WilsonCasper$1K
- Eugene PodrazikCasper$733
- Martin TrottJackson$97K
- Ryan BlackGillette$3K
- Scott BatemanSheridan$906
- David LiuRock Springs$374
- Melissa HertlerLander$314
- Thomas DavisGillette$232
- John RomanoCheyenne$165
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.